Conde-González CJ, Lazcano-Ponce E, Hernández-Girón C, Juárez-Figueroa L, Smith JS, Hernández-Avila M

Language: Spanish
References: 29
Page: 608-616
PDF size: 201.09 Kb.

ABSTRACT

Objective. To determine the seroprevalence of type 2 herpes simplex virus (HSV-2) infection and risk factors in three female population groups in Mexico City. Material and Methods. A cross-sectional study was carried out in 2000, among a sample population of women living in Mexico City, diagnosed with breast or cervical cancer, and women with negative Pap test results from the general population. Informed consent was obtained from all participants to answer a sociodemographic and sex life questionnaire and draw a blood specimen. The presence of antibodies against type 2 herpes simplex virus was determined using the typespecific Western blot technique. Crude and adjusted statistical analyses were performed on the associations between survey data and infection outcomes. Results. Women with cervical cancer had a seroprevalence of HSV-2 infection of 46.8% (191/408); that of women from the general population who were Pap negative was 29.3% (214/730). For women with breast cancer, the seroprevalence was 22.6% (29/128). Variables significantly associated with seropositivity against HSV-2 infection were older age, more sexual partners, having cervical cancer, and, among cervical cancer patients, beginning sexual activity before 21 years of age and being divorced or eparated. Conclusions. Study findings showed statistically significant differences in the prevalence of viral infection by population groups. The overall frequency of viral infection among study subjects shows that this is an intermediate risk population, as compared with other population groups in Mexico at high (sexual workers) and low (college students) risk. The main characteristics associated with exposure to type 2 herpes simplex virus for the subpopulations corresponded, as expected, to sexual behavior and to the probability of infection with older age.

REFERENCES

1. White D, Fenner F. Medical Virology. 4th Ed. New York: Academic Press, USA. 1996: 317-330.

2. Stanberry LR, Jorgensen DM, Nahmias AJ. Herpes simplex viruses 1 and 2. In: Evans AS, Kaslow RA, Ed. Viral infections of humans. Epidemiology and Control. 4th Ed., New York: Plenum Medical Book Company. 1997: 419-454.

3. Nahmias AJ, Lee FK, Beckman-Nahmias S. Seroepidemiological and sociological patterns of Herpes simplex virus infection in the world. Scand J Infect Dis 1990; 69(Suppl): 19-36.

4. Uribe-Salas F, Hernández-Avila M, Juárez-Figueroa L, Conde-Glez CJ, Uribe-Zúñiga P: Risk factors for HSV type 2 infection among female CSW in Mexico City. Int J STD AIDS 1999; 10: 105-111.

5. Conde-Glez CJ. Enfermedades de transmisión sexual., México, DF: Intersistemas, 1999.

6. Zamilpa-Mejía LG, Uribe-Salas F, Juárez-Figueroa L, Calderón-Jaimes E, Conde-González CJ. Prevalencia y factores asociados para sífilis y herpes genital en dos grupos de población femenina. Salud Publica Mex 2003; 45 (supl)5:S617-S623.

7. Conde-Glez CJ, Juárez-Figueroa L, Uribe-Salas F, Hernández-Nevárez P, Schmid DS, Calderón E et al: Analysis of herpes simplex virus 1 and 2 infection in women with high risk sexual behaviour in Mexico. Int J Epidemiol 1999; 28: 571-576.

8. Cowan FM, Johnson AM, Ashley R, Corey L, Mindel A. Antibody to herpes simplex virus type 2 as serological marker of sexual lifestyle in populations. Br Med J 1994; 309: 1325-1329.

9. Wald A, Koutsky L, Ashley RL, Corey L. Genital herpes in a primary care clinic. Demographic and sexual correlates of herpes simplex type 2 infections. Sex Transm Dis 1997; 24: 149-155.

10. Dada AJ, Ajayi AO, Diamondstone L, Quinn TC, Blattner WA, Biggar RJ. A serosurvey of Haemophilus ducreyi, syphilis and herpes simplex virus type 2 and their association with human immunodeficiency virus among female sex workers in Lagos, Nigeria. Sex Transm Dis 1998; 25: 237-242.

11. Hernández-Avila M, Lazcano E, Berumen J, Cruz A, Alonzo P, González L. Human papillomavirus 16-18 infection and cervical cancer in Mexico: A case-control study. Arch Med Res 1997; 28: 265-271.

12. Romieu I, Hernández M, Lazcano E, López L. Breast cancer and lactation history in Mexican women. Am J Epidemiol 1996;143: 543-552.

13. Lazcano-Ponce E, Hernández-Avila M, López-Carrillo L, Alonso de Ruiz P, González-Lira G, Torres-Lobatón A et al. Factores de riesgo reproductivo e historia de vida sexual asociados a cáncer cervical en una muestra de mujeres de la Cd. de México. Rev Invest Clin 1995;47: 377-385.

14. Sánchez D, Pellet PE. Expression of HSV-1 and HSV-2 glycoprotein G in insect cells by using a novel baculovirus expression vector. Virology 1991;182: 229-238.

15. Sánchez-Martínez D, Schmid DS, Whittington W, Brown D, Reeves WC, Chatterjee S et al. Evaluation of a test based on baculovirusexpressed glycoprotein G for detection of herpes simplex virus typespecific antibodies. J Infect Dis 1991;164: 1196-1199.

16. Bronfman M, Guiscafré H, Castro V, Castro R, Gutiérrez G. Medición de la desigualdad: una estrategia metodológica, análisis de las características socioeconómicas. Arch Invest Med 1988;19: 351-360.

17. Hernández-Girón C, Uribe-Salas F, Conde-González C, Cruz-Valdez A, Juárez-Figueroa L, Uribe-Zúñiga Patricia et al. Seroprevalencias a diversos virus y características sociodemográficas en mujeres que buscan detectarse VIH. Rev Invest Clin 1997; 49: 5-13.

18. Uribe-Salas F, Hernández-Avila M, Conde-Glez CJ, Juárez-Figueroa L, Allen B, Anaya-Ocampo R et al. Low HIV and STD prevalence in a random sample of female commercial sex workers in Mexico City. Am J Public Health 1997; 87: 1012-1015.

19. Lazcano-Ponce E, Smith J, Muñoz N, Conde-Glez CJ, Juárez-Figueroa L, Cruz A et al. High prevalence of antibodies to herpes simplex virus type 2 among middle-aged women from Mexico City: A population based study. Sex Transm Dis 2001; 28: 270-276.

20. van de Laar MJ, Termorshuizen F, Slomka MJ, van Doornum GJ, Ossewaarde JM, Brown DW et al. Prevalence and correlates of herpes simplex virus type 2 infection: Evaluation of behavioural risk factors. Int J Epidemiol 1998; 27: 127-134.

21. van Benthem BHB, Spaargaren J, van den Hoek JAR, Merks J, Coutinho RA, Prins M. Prevalence and risk factors for HSV-1 and HSV-2 antibodies in European HIV infected women. Sex Transm Infect 2001; 77: 120-124.

22. Fleming DT, McQuillan GM, Johnson RE, Nahmias AJ, Aral SO, Lee FK et al. Herpes simplex virus type 2 in the United States, 1976 to 1994. N Engl J Med 1997; 337: 1105-111.

23. Safrin S, Arvin A, Mills J, Ashley R. Comparison of Western immunoblot assay and a glicoprotein G enzyme immunoassay for detection of serum antibodies to herpes simplex virus type 2 in patients with AIDS. J Clin Microbiol 1992; 30: 1312-1314.

24. Ashley RL, Wald A. Genital herpes: Review of the epidemic and potential use of type-specific serology. Clin Microbiol Rev 1999; 12: 1-8.

25. Uribe-Salas F, Hernández-Girón C, Conde-González C, Cruz-Valdez A, Juárez-Figueroa L, Hernández-Avila M. Características relacionadas con ETS/VIH de hombres que trabajan en bares de la ciudad de México donde se ejerce la prostitución femenina. Salud Publica Mex 1995; 37: 385-393.

26. Uribe-Salas F, Conde-Glez CJ, Juárez-Figueroa L, Hernández A. Sociodemographic dynamics and sexually transmitted infections in female sex workers at the Mexican-Guatemalan border. Sex Transm Dis 2003; 30: 266-271.

27. Abraham CD, Conde-Glez CJ, Cruz-Valdez A, Zamorano-Sánchez L, Hernández-Márquez C, Lazcano-Ponce E. Sexual and demographic risk factors for herpes simplex virus type 2 according to schooling level among Mexican youths. Sex Transm Dis 2003; 30: 549-555.

28. Sánchez-Alemán M, Uribe-Salas F, Conde-Glez C. High risk sexual behavior and herpes simplex type 2 infection in Mexican college students. Int J STD AIDS 2002; 13 (Suppl): 45-46.

29. World Health Organization. Estimation of the incidence and prevalence of sexually transmitted infections. Report of a WHO consultation; 2002 February 27-March 1; Treviso, Italy. Disponible en:www.who.int/hiv/pub/whohiv200214.pdf.